 |
|
|
| |
ALG-020572, a GalNAc-conjugated Antisense Oligonucleotide, Demonstrates In Vivo Efficacy and Favorable Preclinical Profile for the Treatment of Chronic Hepatitis B
|
| |
| |
AASLD 2021 Nov 12-15
Kusum Gupta1, Jin Hong1, Kha Le1, Dinah Misner1, Vikrant Gohil1, Hua Tan1, Hyunsoon Kang1, Min Luo1, Sandra Chang1, Michelle Schweiger1, Rajendra Pandey1, Vivek K. Rajwanshi1, Megan Fitzgerald1, Felix Lai1, Meenakshi Venkatraman1, Mathew McClure1, Sushmita Chanda1, John Fry1, David B. Smith1, Julian A. Symons1, Lawrence M. Blatt1, Leonid N. Beigelman1, and Tse-I Lin2
1Aligos Therapeutics, Inc., South San Francisco, CA; ²Aligos Belgium BV, Leuven, Belgium
|
| |
|
|
|
|
|
